Related Experiment Videos

Cell death signalling mechanisms in heart failure

Wajihah Mughal1, Lorrie A Kirshenbaum

  • 1The Institute of Cardiovascular Sciences, St Boniface General Hospital Research Centre, Department of Physiology, Faculty of Medicine, University of Manitoba, Winnipeg, Manitoba.

Experimental and Clinical Cardiology
|December 2, 2011
PubMed

Insights

Heart failure involves limited myocardial repair and unclear cell death pathways, including autophagy and programmed necrosis. Understanding these mechanisms is crucial for developing effective treatments for cardiac disease.

Area of Science:

  • Cardiovascular Research
  • Cellular Biology
  • Pathophysiology

Background:

  • Cardiac disease is a growing global epidemic.
  • Myocardial injury leads to limited repair capacity and heart failure.
  • The roles of autophagy, apoptosis, and programmed necrosis in heart failure are not fully understood.

Purpose of the Study:

  • To highlight cell death modes in heart failure.
  • To explore the role of B-cell lymphoma-2 family members.
  • To elucidate the function of mitochondria in directing cell death.

Main Methods:

  • Literature review on cell death mechanisms in cardiac disease.
  • Analysis of signaling pathways involved in myocyte death.
  • Investigation of the role of Bcl-2 family proteins and mitochondrial function.

Main Results:

  • Autophagy can contribute to cell death, presenting an adaptive or maladaptive response.
  • Apoptotic and programmed necrosis pathways in myocytes are critical but incompletely understood.
  • Mitochondria are central organelles in regulating these cell death pathways.

Conclusions:

  • Further research into myocyte cell death mechanisms is essential for treating heart failure.
  • Understanding the balance between adaptive and maladaptive cell death is key.
  • Targeting Bcl-2 family members and mitochondrial pathways may offer therapeutic strategies.

Keywords:
ApoptosisCell DeathHeart failureMitochondriaProgrammed necrosis

Related Concept Videos

Pathophysiology of Heart Failure01:17

Pathophysiology of Heart Failure

Heart failure (HF) is a progressive syndrome involving ventricles that leads to inadequate cardiac output. It can be classified based on location and output or ejection fraction. Ejection fraction (EF) is an essential measurement in the diagnosis and surveillance of HF. Reduced EF corresponds to systolic heart failure (HFrEF). However, HF with preserved ejection fraction (HFpEF) is becoming increasingly prevalent. Also known as diastolic HF, this form of HF is related to aging. The...
Heart Failure II: Pathophysiology01:29

Heart Failure II: Pathophysiology

Systolic Heart Failure and Compensatory MechanismsSystolic heart failure (also termed HFrEF, Heart Failure with Reduced Ejection Fraction) is the most prevalent type of heart filure. It results in a decreased volume of blood being pumped from the ventricle. The aortic arch and carotid sinuses have baroreceptors that detect reduced blood pressure, triggering the sympathetic nervous system (SNS) to release epinephrine and norepinephrine. Initially, this response aims to boost heart rate and...
Heart Failure I: Introduction01:27

Heart Failure I: Introduction

Heart failure refers to a clinical syndrome caused by structural or functional cardiac disorders that prevent the heart from pumping an adequate amount of blood to meet the body's metabolic needs. This condition often arises from myocardial infarction or ischemia, leading to decreased cardiac output, reduced tissue perfusion, impaired gas exchange, fluid volume imbalance, and decreased functional ability.Heart failure can result from disruptions in the mechanisms that regulate cardiac output...
Cardiomyopathy II: Dilated Cardiomyopathy01:30

Cardiomyopathy II: Dilated Cardiomyopathy

Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...
Overview of Cell Death01:30

Overview of Cell Death

Cell death is an essential process where the body gets rid of old or damaged cells. Cell proliferation and death need to be balanced, as an imbalance between the two may lead to cancer or autoimmune diseases.
Cell death was observed in the early 19th century, but there was no experimental evidence to prove it. In 1842, Carl Vogt first discovered cell death in a metamorphic toad; however, it was not termed ‘cell death.’ Scientists discovered different cell death pathways only in the 20th century...
Heart Failure IV: Classification and Diagnostic Evaluation01:30

Heart Failure IV: Classification and Diagnostic Evaluation

Heart failure can be classified in various ways, with the most common classifications based on physical activity limitations, disease progression, severity, and treatment strategies.The Functional Classification of Heart Failure divides patients into four categories based on physical activity limitation due to symptom burden.Class I: Patients in this class have cardiac disease but no physical activity limitations. Ordinary activities like walking, climbing stairs, or routine tasks do not cause...